BSE · 530665
Zenith Health Care Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹12 Cr with net profit ₹0 Cr — a 0.57% net margin, versus 1.38% the period before.
Shareholding
As of 2026-06-30
- Promoter28.74%
- Public70.87%
- DII0.39%
38,725 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.24× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — GSM · GSM 0. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Pharmaceuticals - Indian - Formulations · ranked #39 of 50 by market cap · medians across 42 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Torrent Pharmaceuticals Limited | ₹1,85,562 Cr | 423.85 | 22.06 | 25.49% | 15.55% |
| Ajanta Pharma Limited | ₹42,434 Cr | 159.09 | 9.4 | 23.33% | 19.37% |
| Gland Pharma Limited | ₹41,961 Cr | 114.27 | 4.05 | 9.92% | 15.98% |
| Rubicon Research Limited | ₹25,264 Cr | 326.41 | 19.62 | 19.14% | 14.07% |
| Caplin Point Laboratories Ltd. | ₹19,863 Cr | 116.76 | 5.54 | 17.88% | 29.32% |
| Eris Lifesciences Limited | ₹19,767 Cr | 69.25 | 5.06 | 15.87% | 19.89% |
| Shilpa Medicare Ltd. | ₹11,825 Cr | 109.73 | 4.56 | 9.39% | 15.81% |
| Marksans Pharma Limited | ₹11,757 Cr | 79.34 | 3.89 | 13.82% | 14.16% |
| Senores Pharmaceuticals Limited | ₹6,071 Cr | 165.62 | 6.51 | 12.36% | 18.59% |
| Bliss GVS Pharma Ltd. | ₹4,836 Cr | 141.61 | 4.04 | 8.95% | 11.15% |
| Zenith Health Care Ltd.(this company) | ₹17 Cr | — | 2.28 | 7% | 0% |
AI analysis
AI-generated · google/gemini-2.5-flashZenith Health Care Ltd. is listed on the Indian markets with a market capitalization of Rs 19 Cr. The company reported revenue of Rs 11.76 Cr. Its promoter holding stands at 28.7381% as of March 31, 2026. The stock is currently under the Graded Surveillance Measure (GSM) framework.
Positives
- +The company has a low debt-to-equity ratio of 0, indicating negligible reliance on borrowed capital.
- +Promoter shareholding in the company remains unpledged, with 0% of promoter shares pledged.
- +Return on Equity (ROE) is 7%, indicating the company's ability to generate profit from shareholders' investments.
- +The number of shareholders increased from 8,818 in June 2016 to 39,077 in March 2026.
Negatives
- −The latest annual net profit in March 2025 was Rs 0.067 Cr, a decrease from Rs 0.2035 Cr in March 2024.
- −Quarterly net profit was negative at -Rs 0.34 Cr in March 2026, down from Rs 0.22 Cr in December 2025.
- −The company's profit margin is 0%, indicating very low profitability relative to revenue.
- −EBITDA has shown a decline, from Rs 0.2912 Cr in March 2025 to -Rs 0.42 Cr in March 2026.
- −Return on Capital Employed (ROCE) is low at 0.3327%.
Financial performance
Zenith Health Care Ltd.'s annual revenue was Rs 11.7611 Cr in March 2025, a decrease from Rs 14.7349 Cr in March 2024. Net profit for March 2025 was Rs 0.067 Cr, down from Rs 0.2035 Cr in March 2024. Diluted EPS for March 2025 stood at Rs 0.013, compared to Rs 0.038 in the previous year. Quarterly revenue for March 2026 was Rs 2.62 Cr, marking a decrease from Rs 2.48 Cr in December 2025.
Profitability & returns
The company reported a Return on Equity (ROE) of 7%, while Return on Capital Employed (ROCE) was 0.3327%. The profit margin for the latest annual period was 0%. In March 2026, the net profit was -Rs 0.34 Cr, resulting in negative profitability for the quarter. EBITDA for March 2026 was -Rs 0.42 Cr.
Balance sheet
Zenith Health Care Ltd. has a book value per share of Rs 1.38. The company's debt-to-equity ratio is 0, indicating no debt on its books. This suggests a conservative approach to financing operations.
Ownership & pledges
As of March 31, 2026, the promoter holding in Zenith Health Care Ltd. was 28.7381%. Public shareholding was 70.8693%, and DIIs held 0.3926%. There were no shares pledged by the promoters. The number of shareholders reached 39,077 in March 2026, an increase from 8,818 in June 2016.
Regulatory & surveillance
Zenith Health Care Ltd. is currently under the Graded Surveillance Measure (GSM). Specifically, it is categorized under 'GSM · GSM 0', which indicates certain surveillance actions by the exchange. This measure is implemented to ensure market integrity and safeguard investor interests.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.